On Monday, Merck & Co Inc MRK introduced the acquisition of WuXi Vaccines‘ manufacturing website in Dundalk, Co Louth, marking a big enlargement of its operations in Eire.
The $520.1 million (500 million euros) funding highlights Merck’s dedication to the area. It builds on a 3 billion euro funding in Eire over the previous three years.
The transfer aligns with Merck’s broader development technique, which incorporates plans so as to add roughly 1,000 jobs nationwide within the coming yr.
Additionally Learn: Massive Biopharma Trails Behind The Market: JP Morgan’s 2025 Outlook on Eli Lilly, Merck, and Extra
The Dundalk facility, spanning 15,520 sq. meters, is a three-story manufacturing hub.
It homes drug substance and product manufacturing items and high quality management laboratories devoted to producing vaccine merchandise for world distribution. The positioning presently employs round 200 professionals and plans to rent an extra 150 employees.
The acquisition brings Merck’s complete places in Eire to eight, overlaying Carlow, Cork, Dublin, Louth, Meath and Tipperary. Over 3,000 individuals are employed throughout the community.
Merck and WuXi Vaccines at the moment are coming into a proper handover course of, anticipated to conclude within the first half of 2025. As soon as full, the power will bolster Merck’s capability to satisfy the rising world vaccine demand.
In 2024, Merck introduced a 1 billion euro funding throughout its Carlow and Dunboyne amenities, additional showcasing its dedication to scaling its Irish operations.
Value Motion: MRK inventory is up 0.24% at $99.96 in the course of the premarket session finally test Tuesday.
Learn Subsequent:
Market Information and Knowledge dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
